Thursday, May 28, 2026

Personal Finance

Is This 6.7% Yielder a Home Run?

Every time I see the ticker symbol for PagSeguro Digital (NYSE: PAGS), it reminds me of a guy I lived with in college. We were both big New York Yankees fans, and at the time, the Yanks had a...

Stocks vs. Index Funds: Which Should You Buy?

One of the most common questions I receive is “Should I invest in individual securities or a fund/ETF?” I’m a believer in buying individual stocks and bonds, but for investors who don’t have the time or desire to research...

What You Need to Know About the #1 New Technology

Editor’s Note: Below, Dr. Mark Skousen, The Oxford Club’s Macroeconomic Strategist, reveals the one area of the tech sector he’s watching extremely closely right now. Also, a quick housekeeping note: We will not be sending Wealthy Retirement on Monday...

Is EchoStar’s Rally Asking Too Much?

EchoStar (Nasdaq: SATS) has a story investors can understand. It owns a mix of wireless, pay TV, broadband, and satellite assets, and the market is looking for hidden value in that mix. The cash story is harder. A higher...

T. Rowe Price: Two Sides to the Story

T. Rowe Price (Nasdaq: TROW) manages $1.8 trillion for clients and offers more than 100 mutual funds and ETFs. The stock sports a generous 5% yield. Let’s see if that yield is likely to be maintained. T. Rowe Price generated...

The Bedrock of Your Retirement Portfolio

Last week, I received one of the greatest emails of my career. I write a dividend growth newsletter called The Oxford Income Letter and also run a few VIP Trading Services, one of which is called Weekly Income Alert....

Why Austrian Economics Matters More Than Ever for Investors

If you’ve been watching the markets lately, you know something feels… off. Stocks rally on bad news. Inflation cools – then heats up again. The Fed says one thing, then does another. Many investors are confused. And when people are confused, they...

An Era of Unprecedented Prosperity

Editor’s Note: When it comes to innovation and high-growth opportunities, Chief Investment Strategist Alexander Green may be as plugged in as anyone I’ve ever met. Below, he explains why being a “rational optimist” is key to identifying cutting-edge companies…...

A Biotech Stock Worth More Than Hype?

There are two kinds of businesses that are challenging to value outright. The first are banks. The second is the focus of this week’s column. Biotech firms more often than not can look like make-believe businesses. Many have no major...

“Being Short a Bubble Sucks”

Editor’s Note: Today’s guest article comes from JC Parets, a Chartered Market Technician and the Founder of TrendLabs. JC’s stated mission is “to decode market behavior using pure technical analysis to reveal the truth behind every move.” I met...
- Advertisement -spot_img

Latest News

Dua Lipa Uses This $19 Internet-Famous Face Mask

As a beauty editor, I could say a lot about Dua Lipa's beauty aesthetic. There's her signature...
- Advertisement -spot_img